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a b s t r a c t
In the tissue engineering (TE) field, the concept of producing multifunctional scaffolds, capable not only
of acting as templates for cell transplantation but also of delivering bioactive agents in a controlled
manner, is an emerging strategy aimed to enhance tissue regeneration. In this work, a complex hybrid
release system consisting in a three-dimensional (3D) structure based on poly(d,l-lactic acid) (PDLLA)
impregnated with chitosan/chondroitin sulfate nanoparticles (NPs) was developed. The scaffolds were
prepared by supercritical fluid foaming at 200bar and 35 ◦C, and were then characterized by scanning
electron microscopy (SEM) and micro-CT. SEM also allowed to assess the distribution of the NPs within
the structure, showing that the particles could be found in different areas of the scaffold, indicating a
homogeneous distribution within the 3D structure. Water uptake and weight loss measurements were
also carried out and the results obtained demonstrated that weight loss was not significantly enhanced
although the entrapment of the NPs in the 3D structure clearly enhances the swelling of the structure.
Moreover, the hybrid porous biomaterial displayed adequatemechanical properties for cell adhesion and
support. The possibility of using this scaffold as a multifunctional material was further evaluated by the
incorporation of a model protein, bovine serum albumin (BSA), either directly into the PDLLA foam or
in the NPs that were eventually included in the scaffold. The obtained results show that it is possible to
achieve different release kinetics, suggesting that this system is a promising candidate for dual protein
delivery system for TE applications.
© 2010 Elsevier B.V. All rights reserved.
1. Introduction
In tissue engineering (TE), a porous scaffold is typically required
to act as a template for cell proliferation, differentiation and cell
growth. Scaffolds may also act as controlled release devices that
deliver growth factors (GFs) with rates matching the physiological
needof the regenerating tissue. Theprocessofnewtissue formation
maybeaugmentedby thedeliveryofbioactive factors (e.g.GFs) that
induce cells to behave in a specific manner [1]. The aim of targeted
drug delivery is to selectively deliver drugs/bioactive agents to spe-
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cific sites and to release them locally in order to induce a desired
response of the target tissue, without affecting the surrounding
tissues. Recently some studies [2–5] have reported the incorpo-
ration of drug or protein-loaded particles into TE scaffolds to form
composites with the ability of delivering bioactive molecules that
aid in tissue regeneration [6]. Ideally, the concept of delivering
bioactive agents directly from the polymer matrix which is used
as a template for cell transplanting is an attractive approach. How-
ever, the major challenge in developing drug delivery systems is to
incorporate such biologically active guest species, without loss or
change of activity, into a polymeric host. In the case of proteins, the
major challenges in developing protein-encapsulated systems are
[7,8]: (i) instability of encapsulated proteins; (ii) their incomplete
release, and (iii) initial burst release. One of the major advantages
of a sustained delivery approach is the possible reduction in the
required cumulative dose, which is an advantage in order to avoid
supraphysiological levels of proteins and to reduce the cost of the
therapy [9]. Tissue morphogenesis and regeneration are typically
driven by concomitant action of multiple factors, which can work
0896-8446/$ – see front matter © 2010 Elsevier B.V. All rights reserved.
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synergistically on the same process, or can target different barriers
to regeneration [10]. Temporal and spatial control of the release of
such factors is crucial to a successful tissue repair and regeneration
[11].
In this work, we propose a novel hybrid scaffold composed of
a poly(d,l-lactic acid) (PDLLA) porous scaffold incorporating chi-
tosan/chondroitin sulfate (CH/CS) nanoparticles (NPs) for ultimate
application on the TE field.
PDLLA is a well known biodegradable material because of its
excellent mechanical strength [12–14] and it has been commonly
used for fabricating biocompatible and porous scaffolds [13,15,16].
However, PDLLA is a hydrophobic material that retards the diffu-
sion of water molecules into its matrix, and so it takes a long time
to degrade [12]. Common scaffold fabrication techniques include
solvent casting/salt leaching [17], moulding/salt leaching [18], and
gas foaming/salt leaching [19]. Theseconventionalmethods require
the use of organic solvents and/or high processing temperatures,
which can prohibit their use in the preparation of GF-loaded scaf-
folds. Additionally, someof thementioned techniquesmight lead to
the loss of fractions of the entrappedGFandalsobeharmful for cells
andnearby tissues [20]. In order to overcome these limitations, car-
bon dioxide (CO2) has been used as a plasticizer and foaming agent
to formthree-dimensional (3D) scaffolds [15]. Remarkableprogress
has been made in the application of dense gases to the process-
ing of polymers over the last decade. Gas foaming technology [21],
crosslinking reactions at high pressure CO2 [22] and supercritical
CO2-water emulsion techniques [23] have been used to fabricate
porous hydrogels or scaffolds fromdifferent kinds of polymers [24].
CO2 is inexpensive, non-toxic andnon-flammable and readily avail-
able in high purity from a variety of sources. Supercritical carbon
dioxide (scCO2) combines gas-like diffusivity with the liquid-like
density, which makes it a unique medium for polymer synthesis
and processing [15,22,24].
However, despite the obvious advantages, this technique
presents some clear limitations. The control over internal scaffold
architecture cannot approach that of, for instance, the 3D printing
technique. Also the range of polymer types for which supercritical
fluids (SCFs) are applicable might be limiting in some applications,
particularly where high mechanical strength is required [11]. The
ability toplasticizepolymersat close to37 ◦Cand the inherently low
solubility of proteins in scCO2 provides a keyprocessing advantage;
thermal and solvent labile species can be processed easily whilst
preserving protein structure and function [11,25].
Richardson et al. [26] also applied the gas foaming/salt leaching
approach for the simultaneous encapsulationof twoangiogenicGFs
– vascular endothelial growth factor (VEGF) and platelet derived
growth factor (PDGF) – in poly(lactide-co-glycolide) (PLG) foams
for dual release, with tailored release profiles. In this case, PDGF
was pre-encapsulated in PLG microspheres while VEGF was dis-
persed in an alginate powder, generating the different kinetics. The
dual delivery of these two GFs promoted the formation of a vas-
cular network in vivo to a greater extent than either of the two GF
delivered alone [26]. The drawback of this strategy is the use of salt
leaching step, which removes some of the incorporated bioactive
material [11].
Several reports [1,27–36] have shown that SCF technology
seems appropriate for the development of appropriate architec-
tures for TE applications, with the inclusion of the biological cues
for further stimulation of cell behaviour and enhancement of tis-
sue regeneration. Some other studies [2–4,10,37–40] have already
addressed the application of dual release systems for TE purposes.
Encouraging resul1ts have been obtained in the enhancement of
bone and cartilage regeneration, as well as improved vascularisa-
tion.
To our knowledge, noworks have been published on the entrap-
ment of NPs into polymeric sponges by gas foaming procedure.
Chen et al. [41] reported the microencapsulation of pueranin NPs
by PLA. In our study, CH/CS NPs previously developed in our group
[42],whichhave shown tobe able to release proteins in a controlled
manner,were entrapped in the PDLLA foam. Bovine serumalbumin
(BSA) was used as model protein to assess the entrapment and in
vitro release kinetics, in order to study the potential application of
this PDLLA-NPs hybrid structure for dual protein release with dis-
tinct kinetics. The protein dispersed in the PDLLA polymer should
be released at a faster pace, while the protein entrapped in the NPs
should be delivered in slower fashion.
2. Experimental procedure
2.1. Materials
Lowmolecular weight (116kDa) chitosan (CH) (448869), chon-
droitin sulfate (CS) (C9819), bovine serum albumin (BSA/A2153, pI
5.3), phosphate buffered saline tablets (PBS), Dulbecco’s modified
Eagle’s medium low glucose, Dulbecco’s modified Eagle’s medium
without phenol red and sodium bicarbonate were purchased from
Sigma Aldrich (Germany). Fetal bovine serum (FBS) was purchased
from Biochrom AG (Germany) and antibiotic–antimycotic (A/B)
solution from Gibco (Spain). (3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) MTS
reagent was purchased from Promega (UK). Chitosan was further
purified by the precipitation procedure [43], all the other chemi-
cals were used with no further purification. After CH purification,
the final deacetylation degreewas 75–85%. PDLLAwith an inherent
viscosity of 1.87dL/g was purchased from Purasorb. Carbon diox-
ide (99.998mol%) was supplied by Air Liquide. MicroBCA protein
detection kit was purchased from Pierce.
2.2. Preparation of the nanoparticles
Chitosan/chondroitin sulfate nanoparticles (CH/CS NPs) were
prepared as described previously by Santo et al. [42]. Briefly, CH
was dissolved in 1% (w/v) acetic acid while CS was dissolved in dis-
tilled water at room temperature, to obtain solutions of 6mg/mL
and 0.81–0.94mg/mL, respectively, in order to reach final theoret-
ical CH/CS ratio of 1/1 (w/w). The NPs suspension spontaneously
occurred when the CH solution was added to the CS solution,
under strong magnetic stirring at room temperature. To prepare
the protein-loaded CH/CS NPs, BSA (pI 5.3) was dissolved in water
and furthermixed in the CS solution afterwards. Following a 10min
centrifugation at 11,500× g, the supernatants were discarded and
the NPs were isolated. The protein concentrations used for this
study were such that allowed the preparation of NPs with 15%
(w/w) of protein respective to the NP content.
2.3. Supercritical fluid foaming
The scaffoldswere prepared by SCF foaming at 200bar and 35 ◦C
in a high pressure equipment especially designed for this purpose.
In each experiment ca. 100mg of PDLLA was loaded in a mould,
which was placed inside the high pressure vessel. The vessel was
heated in by means of an electric thin band heater (OGDEN, USA)
connected to a temperature controller, whichmaintained the tem-
perature within ±1 ◦C. Carbon dioxide was pumped into the vessel
using a high pressure piston pump (P-200A Thar Technologies)
until the operational pressure was attained. The pressure inside
the vessel was measured with a pressure transducer. The system
was closed for 30min to allow the plasticization of the polymer.
Afterwards the system was slowly depressurized (ca. 5 bar/min).
When BSA and/or the NPs were loaded in the 3D construct, they
were previously suspended in ethanol and afterwards added to the
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PDLLA powder in the mould. The SCF foaming procedure was the
same as the above described.
2.4. Scaffold characterization
Scanning electron microscopy (SEM): samples of the scaffolds
prepared were observed under a scanning electron microscope
(Leica Cambridge, Model S360, UK). The matrices were cut after
being frozen with liquid nitrogen and coated with gold palladium
using a sputter coater (JEOL JFC-1100).
Micro-computed tomography (!-CT): The inner structure,
porosity and interconnectivity were evaluated by micro-
computerized tomography using a micro-CT scanner (Skyscan
1702, Belgium) with penetrative X-rays of 40keV. The X-ray scans
were acquired in high-resolution mode. CT Analyser® software
was used to visualize and reconstruct the 2D X-ray sections images
of the scaffolds.
2.5. Water uptake and degradation
The swelling capability of the prepared matrices was assessed
by measuring the water uptake of the samples for a period up to
21 days. Pre-weighed scaffolds, prepared by SCF foaming, were
immersed in 10mL of PBS at pH=7.4. The samples were placed
in a water bath at 37 ◦C. After predetermined periods of time (1, 3,
7, 14 and 21 days) the sampleswereweighed in order to determine
the water uptake of the scaffolds.
Water uptake was determined using the following equation:
% water uptake = ww −wd
wd
× 100 (1)
where ww is the weight of the wet sample and wd is the weight of
the dry sample.
After each time period the samples were dried and weighed to
determine the weight loss, which was calculated according to the
equation:
%weight loss = ww −wi
wi
× 100 (2)
where wf is the weight of the dry sample after immersion and wi
is the initial weight of the sample.
The pH of each solution was also measured in order to follow
the release of acidic degradation products into the medium.
The data presented is the result of the average of at least three
measurements.
2.6. Mechanical properties
Compressive mechanical properties of the scaffolds prepared
were measured using an INSTRON 5543 (Instron Int. Ltd., High
Wycombe, UK) universal testing machine with a load cell of 1 kN.
Test samples were obtained by cutting the scaffolds into a cylin-
drical shape with 8mm diameter and 8mm height. Compression
testing was carried out at a crosshead of 2mm/min, until obtaining
a maximum reduction in samples height of 60%. The compressive
modulus is defined as the initial slope on the stress/strain curves.
The data presented is the result of the average of at least three
measurements.
2.7. Protein release studies
In vitro release studies of BSA from PDLLA foams and PDLLA-NPs
hybrid structures were performed by incubating the protein-
loadedmaterials in 5mL of PBS, at pH 7.4 under horizontal shaking
at 37 ◦C. The release was performed in sink conditions. At appro-
priate time intervals, aliquots of 1mL were withdrawn and fresh
volume of PBS was added to the suspension to replace the sample.
The samples were quantified by the microBCA protein detection
kit and the optical density was read at 562nm, on a multiwell
microplate reader (Synergy HT, Bio-Tek Instruments, USA). The
results were presented as an average of three measurements. BSA
was loaded either directly to the PDLLA foamor into theNPs, which
were then foamed together with the polymer. When the BSA was
loaded directly into the scaffold, 200 and 500!g were entrapped
in the 3D structure, both for the PDLLA-only scaffold and for the
PDLLA-NPs hybrid structure.
2.8. Cytotoxicity screening studies
In order to assess the eventual cytotoxicity of the scaffolds,
extracts of the materials were prepared and placed in contact
with a mouse fibroblast-like cell line (L929 cells; ECACC, UK) and
tested using a MTS assay in accordance to ISO/EN 1099317. Cells
were cultured in basic medium composed of Dulbecco’s modi-
fied Eagle’s medium (DMEM) with phenol red and supplemented
with 10% foetal bovine serum and 1% antibiotic/antimycotic
solution. A diluted cell suspension with a concentration of
4×103 cellsmL−1 was prepared, seeded onto 96-well plates and
incubated for 24h. The extracts prepared in culture medium
were then added to the wells. L929 cells viability was deter-
mined for each extract and compared to latex extracts, used
as a positive control of cell death. After 72h of incubation
MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-
2-(4-sulfophenyl)-2H-tetrazolium) test was performed to assess
cellular viability of L929 cells in contact with extracts. The optical
density (OD) was read at 490nm, on amultiwell microplate reader
(Synergy HT, Bio-Tek Instruments, USA). All cytotoxicity screening
tests were performed using 3 replicates.
3. Results and discussion
The concept of TE has long pass the idea of constructing an inert
matrix to serve merely as support for cells and tissue growth in
the defect site. Instead the use of the scaffold as an active structure
to help tissue regeneration is the main target of future therapeu-
tics. In this context, the delivery of biomacromolecules, able to
signal and direct tissue growth, is of major importance. In this
work we evaluated the possibility of developing a novel hybrid
3D matrix using the SCF technology. PDLLA foams were success-
fully prepared at 200bar and 35 ◦C. The pore size and structure
of the PDLLA porous scaffolds produced using scCO2 can be tai-
lored by themodification of the processing conditions. The applied
foaming conditions were selected after the work of Tai and co-
workers [15]. The selected temperature is close to the physiological
temperature and it limits the denaturation of the incorporated
biomacromolecules. Moreover, PDLLA shows negligible solubility
in scCO2 under the conditions used in this study [15]. Conway et
al. [44] has reported that the solubilisation of even low molecular
weight PDLLA requires extreme conditions.
The novelty of the developed system arises from the incor-
poration of CH/CS NPs, which may enhance the potential of this
system to act as a dual drug delivery carrier. These NPs result from
complexation between two naturally-derived, oppositely-charged
polymers, which are of especial interest due to their biological and
chemical similarities to natural tissues [45,46]. This system is also
particularly suited for protein entrapment as CS is one of the most
important glycosaminoglycans (GAGs). In nature, the protection
and regulation of GFs is provided through their interactions with
biopolymers in the extracellularmatrix (ECM), such as proteins and
polysaccharides [47–49]. One of the groups of these molecules are
the proteoglycans, which contain polysaccharides belonging to the
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Fig. 1. 3D structures prepared by SCF foaming at 200bar and 35 ◦C: (a) PDLLA and (b) PDLLA loaded with NPs.
family of GAGs. The storage of GFs in the ECM allows for a better
localization, regulation, and sustainment of GFs’ action as com-
pared to the respective factor in solution thatwould quickly diffuse
out of its location or lose its potency [47,50,51].
These NPs have been developed in a previous work [42] which
has demonstrated the suitability of these systems for the controlled
release of proteins. TheNPspresent a spherical shape and size rang-
ing from 150 to 200nm, as observed by atomic force microscopy
and dynamic light scattering (data not shown), with a normal size
distribution.
The SEM images of the cross-sections of the scaffolds prepared
(Fig. 1) demonstrate the similar morphology of the matrices in
the presence or absence of NPs. Both formulations (Fig. 1(a), (b))
displayed random and interconnected morphological organization
and for the scaffold foamed with the NPs, there is a homogeneous
distribution of the CH/CS complex all over the 3D support.
Themorphologyof theporous structures of 3D scaffolds, namely
their porosity, interconnectivity and pore size diameter, is partic-
ularly important for the application of such materials in TE and
regenerative medicine strategies. Open pores, interconnectivity
and adequate pore size for cell growth and vascularisation are
key requirements for this purpose. Therefore the developed sys-
tems were further characterized using !-CT (Table 1). Micro-CT
allows also a more objective comparison since the porosity and
interconnectivity of the samples can be calculated. The intercon-
nectivity of the scaffold is calculated according to the formula:
I = [(Vtotal pore − Vdisconnectedpore)/Vtotal pore]× 100, where the vol-
ume of the disconnected pore stands for the disconnected pore
volume which was defined to be higher than 50!m. Fig. 2 rep-
resents a 2D image of the PDLLA scaffolds. Furthermore, a 3D
reconstruction of the matrices is also presented.
The homogeneity of the matrices prepared is confirmed by the
Gaussianpore sizedistribution,whichwasobserved for bothPDLLA
and NPs-loaded PDLLA scaffolds. A high surface area/volume ratio
Table 1
Summary of the morphological properties of the scaffolds, obtained by !-CT
analysis.
PDLLA NPs-loaded PDLLA
Porosity (%) 67 56
Interconnectivity (%) 55 39
is needed to assure the mass transport between cells within the
scaffold and the surrounding host tissue [1].
The porosity and interconnectivity values decreased when NPs
were integrated in the 3D foamed PDLLA scaffold, which was
expected due to the addition of another polymeric source into the
matrix. In future work, the influence of these morphological fea-
tures will be further assessed with cell culture, in order to evaluate
if the decrease in these parameters might or not significantly affect
cell proliferation and metabolism.
3.1. Mechanical properties
Mechanical properties of both PDLLA and PDLLA loaded with
NPs were evaluated through compression tests as the microstruc-
tural characteristics of the scaffold may influence its mechanical
properties. Fig. 3 shows, as an example, a representative curve for
the deformation behaviour of the porous constructs.
Usually, stress–strain curves for an open cellular material, in
compression, present a linearelastic regime, aplateauandadensifi-
cation regime [52–54]. Beyond the linear region in the stress/strain
plot, a permanent deformation will occur, pores will start to col-
lapse and the structure is irreversibly damaged. The compressive
modulus was calculated from the initial slope of the curve and it
was found to be 12.1±1.9MPa and 11.3±5.6MPa for PDLLA and
NPs-loaded PDLLA scaffolds, respectively. In general, this material
presents adequate mechanical properties to support new tissue
Fig. 2. Representative micro-CT images of the 2D surface and 3D model (a) PDLLA matrices and (b) NPs-loaded PDLLA matrices.
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Fig. 3. Representative stress deformation curve of PDLLA scaffolds loaded with NPs
(a) and PDLLA scaffolds only (b) prepared at 35 ◦C and 200bar.
growth, which has also been demonstrated in different studies
reported in the literature [53,55].
3.2. Water uptake and degradation studies
The knowledge of both water uptake and weight loss of
the materials prepared is important to study their degradation
behaviour since they are aimed to be used in biomedical applica-
tions, particularly following a drug delivery strategy. Furthermore,
their life time will be governed by these two processes which are
intimately correlated.
Water uptake of the porous structures prepared by SCF foaming
was evaluated for different time periods for samples immersed in
PBS solution. Fig. 4 presents the percentage of water uptake of the
matrices as a function of time.
Fig. 4. Water uptake profile of the scaffolds prepared by SCF foaming (♦) PDLLA and
(") PDLLA loaded with NPs.
The presence of CH/CS NPs dispersed in the scaffold greatly
changes the hydrophylicity of the matrix as it can be observed
in Fig. 4. PDLLA is a hydrophobic synthetic polymer which takes
up more than 6 months to degrade and therefore slowly releases
entrapped proteins [30]. The addition of hydrophilic polymers has
been suggested in previous works [56,57], in order to increase
the water uptake and degradation rate of the polymers, and con-
sequently enhancing the protein release rate. In this case, the
incorporation of the hydrophilic NPs has the described effect over
the water uptake measurements.
Although PDLLA is a widely studied and quite used polymer for
biomedical applications, its major drawback is the fact that it can
elicit undesirable inflammatory and allergenic reactions [58,59]
because of the decrease in the local pH as a consequence of its
hydrolytic degradation. The biodegradation of PDLLA results in the
scission of the polymeric chains to monomer units of lactic acid,
Fig. 5. In vitro BSA release profiles performed at 37 ◦C in PBS, pH 7.4, 60 rpm. (a) One month protein release profiles of the PDLLA scaffolds loaded with different BSA
concentrations and with the evaluation of the effect of the inclusion of the NPs into the 3D structure. The symbol (#) represents the PDLLA scaffold loaded with 500!g of
BSA, ($) represents the empty NPs-loaded PDLLA scaffold, loaded with 500!g of BSA, (%) represents the PDLLA scaffold loaded with 200!g of BSA and (%) represents the
empty NPs-loaded PDLLA scaffold, loaded with 200!g of BSA; (b) overlook of the burst release phase of the graph displayed in (a); (c) one month protein release profiles to
study the effect of the entrapment of the BSA-loaded NPs in the PDLLA scaffold. The symbol ($) represents the release of BSA-loaded NPs (15% (w/w)) and (%) represents the
release of the BSA-loaded NPs (15% (w/w)) entrapped in the PDLLA scaffold; (d) overlook of the burst release phase of the graph displayed in (c).
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as a natural intermediate in carbohydrate metabolism [60]. For
this reason, it is important to monitor the pH of the solution after
different periods of immersion. For the studied time period a sig-
nificant increase in the acidity of themediawas not verified (the pH
remained relatively constant, close to the physiological value), nei-
ther for the PDLLA scaffolds nor for the scaffolds loaded with the
NPs, indicating that the materials suffer a slow hydrolysis degra-
dation process. Furthermore, this is extremely important when
aiming to develop a suitable carrier for biomacromolecules which
are sensitive to large pH variations, such as proteins.
Degradation of the scaffolds was followed by weight loss mea-
surements after the predetermined periods of immersion time in
PBS and both formulations presented low weight loss values. This
was expected as the low rate of degradation of PDLLA has already
been reported [30,61]. While the PDLLA-only scaffolds lost 3% of
the initial weight in a controlled way, the NPs-loaded PDLLA scaf-
folds showed a slightly higher weight loss value (6%) due to the
possible leaching of the particles into themedium, nonetheless the
degradationprocess remains very slow.Moreover, thehigherwater
uptake of the scaffolds incorporating the NPs might enhance their
hydrolytic degradation.
The incorporation of empty NPs into the PDLLA scaffolds guar-
anteed a more controlled protein release kinetic when compared
with the PDLLA scaffolds alone (Fig. 5(a)). The PDLLA-only foams
showed a burst release effect, releasing most of the entrapped BSA
during day 1, for both tested protein loadings – 200 and 500!g. The
initial burst effect is likely due to the delivery of protein bound to
the inner pore surfaces of the scaffold, while the subsequent con-
trolled release is likely due to the diffusion of the incorporated BSA.
Polymer degradation is not expected to be a mechanism of protein
release, since the observed mass loss is not significant [1,15,30].
These results demonstrate that during the foaming process, the
biggest fraction of the protein remains adsorbed in the 3D PDLLA
structure, causing a quick and uncontrolled delivery kinetic.
However, when the CH/CS NPs are included in the foaming pro-
cess, the protein release becomes much more controlled, reducing
both the burst effect (Fig. 5(b)) and the delivery rate at a long-term
basis. One possible explanation for this phenomenon is the elec-
trostatic interaction between the positively charged NPs and the
negatively charged BSA (pI = 5.3), resulting in a strong complex and
delaying the diffusion of the protein out of the scaffold. Moreover,
CS is a sulfated GAG well known for its interaction with proteins
and GFs in the ECM, enhancing their action and assuring their sta-
bility [47]. This mechanism might be happening too in the PDLLA
scaffold, creating strong interactions between CS and BSA.
The development of BSA-loaded CH/CS NPs was also performed
and the release profile was compared with the BSA-loaded NPs
entrapped in the PDLLA foam (Fig. 5(c)). The NPs showed a con-
trolled release profile, delivering the proteins at a constant rate.
When the NPs were included in the scaffold, the burst release
was slightly reduced (Fig. 5(d)), however not displaying significant
differences in a long-term basis. This observation shows that the
entrapment of the NPs in the scaffold did not affect the desired
controlled release rate of the NPs alone. These findings, together
with the improvement on the PDLLA release observed, suggest that
it is possible to obtain several different release profiles using this
hybrid system, which was our ultimate goal for this work.
The potential use of these materials in biomedical applications
demands that they cannot be cytotoxic. Therefore, cytotoxicity
assessment of the matrixes leachables was carried out as a very
preliminary approach to assess their toxicity potential. Fig. 6 shows
the results for the optical density (OD) with the MTS test in
order to assess cell viability after 72h in contact with the pre-
pared extracts. As it can be observed the leachables of the PDLLA
scaffolds and the PDLLA scaffolds loadedwith the NPs are not cyto-
toxic.
Fig. 6. Cytotoxicity screening of the scaffolds through the extracts test. The assay
was performed with the L929 cell line for 3 days of in vitro culture.
4. Conclusions
This work showed the versatility of the SCF foaming proce-
dure, allowing the successful entrapment of polymeric NPs into
PDLLA scaffolds, for the ultimate goal of creating a dual release
system for applications in the TE field. PDLLA foams were already
well described in the literature, however this study has showed
that the inclusion of the CH/CS NPs did not negatively affect
the 3D structure, maintaining adequate porosity and intercon-
nectivity for cell culture, and displaying adequate mechanical
properties. These novel systems are also able to delay the fast
and uncontrolled release of proteins loaded directly into the poly-
meric foam. Moreover, it was possible to design different release
profiles, by means of changing the loading parameters of both
scaffolds and NPs. The non-cytotoxic behaviour of the PDLLA
scaffolds in extraction testswas also not compromisedby the inclu-
sion of the CH/CS complex in the structure. These results show
that this novel hybrid structure composed PDLLA-NPs might be
a promising approach as a multifunctional cell template for TE
purposes, displaying not only adequate morphological parameters
necessary for cell culture but also the ability to deliver bioactive
molecules at different rates for further stimulation of cell/tissue
behaviour.
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